American Academy of Pain Medicine Supports FDA's Initiative to Curb Pain Drug Abuse
American Academy of Pain Medicine has announced its support for the Food and Drug Administration's issuance of the Risk Evaluation Mitigation Strategy for opioids.
AAPM calls REMS a "huge leap forward" and says they are pleased to have worked with the FDA and other groups on the strategy development.
"Through proper education and training, opioids can be administered safely to patients and continue to be an important option in the treatment of chronic and debilitating pain that is suffered by millions of Americans," says the statement.
The organization plans to release a list of best practices for patients and perscribers to reduce adverse outcomes associated with opioids.
More Articles on Pain Management:
Central Phoenix Surgical Center Adds Progenitor Cell Therapy
Tennessee Grants 255 Pain Clinics Licenses Since New Law
Indiana Senator to Sponsor Bill Requiring Pain Clinic Owners be Physicians
© Copyright ASC COMMUNICATIONS 2012. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.
To receive the latest hospital and health system business and legal news and analysis from Becker's Hospital Review, sign-up for the free Becker's Hospital Review E-weekly by clicking here.
- How to Increase Practice Reimbursement: Increased Patients, Increased Cash-Flow
- University Physicians of Brooklyn-Anesthesia Selects OpenTempo for Workforce, Case Management
- Dr. Jeff Benson Joins St. Alexius Heart & Lung Clinic
- Trice Orthopedics Closes Bridge Loan Financing with $3M
- Alliance Imaging, Pinehurst Surgical Expand Imaging Partnership